Added to YB: 2025-04-25
Pitch date: 2025-04-23
DHR [neutral]
Danaher Corporation
+14.62%
current return
Author Info
Best Anchor Stocks shares deep research on companies with long-term potential aThe Bear Cavend lower-than-average volatility. Sign up for the newsletter.
Company Info
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.
Market Cap
$159.9B
Pitch Price
$196.04
Price Target
N/A
Dividend
0.57%
EV/EBITDA
22.21
P/E
46.51
EV/Sales
7.27
Sector
Life Sciences Tools and Services
Category
growth
Is that light at the end of the tunnel? - Danaher Corporation
DHR (earnings update): Beat Q1 expectations, maintained guidance despite macro concerns - signals strong visibility. Bioprocessing emerging from destocking cycle with LDD consumables growth, biotech guide raised to high single digits. $350M tariff impact manageable via DBS, manufacturing shifts, pricing. $1B buybacks in Q1, 4% shares down. FY25 EPS guide $7.68 (midpoint) likely beatable.
Read full article (5 min)